China News Weekly 122 – Trump ratchets up US-China trade war with new tariffs

Mining, Others, Precious Metals, Technology

Innovent and Shenogen to Test PD-1/Brain Cancer Candidate Combo

Life Science

Celltrion Forms JV with Nan Fung to Develop Three Biosimilars in China

Life Science

Novartis’s older MS drug Gilenya wins Chinese approval

Life Science

Toyota, China’s BYD team up to develop battery EVs

Technology

SoftBank raises $270 million via Seoul unit for early-stage investments

Technology

CNRT Raises $14 Million; Will Develop BTG’s TheraSphere® in China

Life Science

Abbisko Acquires China Rights to Anti-Immunosuppresive Drug from Boston’s X4

Life Science

Boehringer Ingelheim Gambles $2.62 Billion on Two Fibrotic Disease Deals

Life Science

Chipscreen Poised to be One of the First IPOs on Shanghai’s STAR Exchange

Life Science

China News Weekly 119 – London Metal Exchange adds Huayou’s cobalt to its approved list

Energy, Life Science, Mining, Technology

Tencent-backed live-streaming firm DouYu prices U.S. IPO at low end of range

Technology

Cipla Forms $30 Million China Respiratory Drug JV with Jiangsu Acebright

Life Science

HitGen Approved for $97 Million IPO on Shanghai’s STAR Board

Life Science

I-Mab Announces IND Approval for Its Proprietary TJC4, A Potentially Differentiated CD47 Antibody, to Initiate Clinical Trials in China

Life Science